Simpson W J, Panzarella T, Carruthers J S, Gospodarowicz M K, Sutcliffe S B
Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Int J Radiat Oncol Biol Phys. 1988 Jun;14(6):1063-75. doi: 10.1016/0360-3016(88)90381-1.
We report the experience from 13 Canadian radiotherapy centres concerning the treatment and outcome for 1074 papillary and 504 follicular thyroid cancer patients followed for 4-24 years. Surgical resection was carried out in almost all patients; there was no correlation between the type of operation and recurrence or survival. Treatment with external irradiation (201 patients) radioiodine (214 patients), or both (107 patients) was used more often in poor prognosis patients than in those with good prognostic factors, and was effective in reducing local recurrences and improving survival, especially in patients with microscopic residual disease postoperatively. Treatment complications were common but rarely fatal. Thyroid cancer was the cause of death in over half of the papillary cancer deaths and in two-thirds of the follicular cancer deaths.
我们报告了来自13个加拿大放疗中心的经验,涉及1074例乳头状甲状腺癌患者和504例滤泡状甲状腺癌患者的治疗及预后情况,这些患者的随访时间为4至24年。几乎所有患者都接受了手术切除;手术类型与复发或生存率之间没有相关性。预后较差的患者比具有良好预后因素的患者更常使用外照射(201例患者)、放射性碘(214例患者)或两者联合(107例患者)进行治疗,并且这在减少局部复发和提高生存率方面是有效的,尤其是对术后有微小残留病灶的患者。治疗并发症很常见,但很少致命。在超过一半的乳头状癌死亡病例和三分之二的滤泡状癌死亡病例中,甲状腺癌是死亡原因。